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Bile acid (BA) hydrophobicity, evaluated by the octanol-water partition coefficient, decreases along the 
series deoxycholic acid - chenodeoxycholic acid - hyodeoxycholic acid - ursodeoxycholic acid - cholic acid 
(CA) - ursocholic acid (UCA). In vitro experiments carried out using dialysis techniques (to determine the 
maximum BA binding) and ultrafiltration of plasma pre-incubated with 0.1 mM BA (to assess the distribu- 
tion of BA between the different lipoprotein fractions) showed that the maximum binding of BA to plasma 
and lipoproteins follows the same order of hydrophobicity. The fraction not bound to proteins, greater with 
the hydrophilic BA (UCA and CA), is distributed in the lipoprotein fractions and in particular in high 
density lipoproteins. 
Bile acid Hydrophobicity Protein Lipoprotein binding 
1. INTRODUCTION 
Physicochemical properties of bile acids (BA) in- 
fluence their biological activities [1,2] and prob- 
ably their circulating fraction. In plasma BA are 
tightly bound to albumin [3,4], but lipoproteins 
can also influence the unbound BA fraction 
available to tissues [5]. 
Surprisingly, in analbuminemia little change in 
anion binding capacity occurs and no variations of 
Abbreviations: VLDL, very low density lipoproteins 
(d < 1.006 g/ml); LDL, low density lipoproteins (d = 
1.030-l .063 g/ml); HDL, high density lipoproteins (d = 
1.063-l .210 g/ml); d > 1.210 g/ml, lipoprotein-free 
fraction; BS, bile salts; BA, bile acids; DCA, deox- 
ycholic acid (3a,l&-dihydroxy-5/3-cholanoic acid); 
CDCA, chenodeoxycholic acid (3a,7a-dihydroxy-5P- 
cholanoic acid); HDCA, hyodeoxycholic acid (3cy,&- 
dihydroxy-5,%cholanoic acid); UDCA, ursodeoxycholic 
acid (3cz,7&dihydroxy-Sfl-cholanoic acid); CA, cholic 
acid (3a,7a,lti-trihydroxy-S,&cholanoic acid); UCA, 
ursocholic acid (3c~,7fl,12cu-trihydroxy-S@cholanoic 
acid); GLC, gas liquid chromatography; TLC, thin layer 
chromatography; HPLC, high performance liquid 
chromatography 
bile formation have been reported [6,?‘]. In this 
condition other plasma proteins and lipoproteins 
[4] can partially compensate for albumin deficien- 
cy El. 
Here we evaluate the in vitro binding of several 
bile salts, having different physico-chemical pro- 
perties, to lipoproteins, the latter possessing bind- 
ing sites for bile salts (BS). In fact surface polar 
components, such as apoprotein and phospholi- 
pids, can interact with BS molecules. 
We studied (a) the maximum BA binding capaci- 
ty of whole plasma and lipoprotein fractions using 
dialysis techniques, and (b) the distribution of dif- 
ferent BS among lipoprotein classes separated by 
ultra-centrifugation. Since BS binding depends on 
their physicochemical properties, we also 
estimated the hydrophobic properties of BS from 
their octan-1-ol-water distribution. 
2. MATERIALS AND METHODS 
2.1. Bile acids 
Sodium salts of BA were obtained by neutraliz- 
ing an alcohol solution with an equivalent amount 
of NaOH; sodium salts were crystallized after the 
addition of ether. 
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Tris buffer, pH 7.5, 0.15 M NaCl containing 
200 mg/l sodium azide was used in the dialysis 
experiments. 
Sterognost 3 Kit (Bracco-Merck, Milan) was 
used for BA determination in an LKB Ultralab 
System 8600 reaction rate analyzer: method sen- 
sitivity was 0.5 /rM/l. 
All chemicals were reagent grade. Water was 
double distilled and decarbonated prior to use. 
2.2. Lipoprotein fraction preparation 
Fasting blood samples were collected in EDTA 
(1 mg/ml) from healthy subjects. Lipoproteins 
(VLDL, LDL, HDL) and the fraction with d > 
1.210 g/ml (lipoprotein-free fraction) were ob- 
tained by sequential ultracentrifugation in an 
L5-65 Beckman ultracentrifuge at 6°C using solid 
potassium bromide to obtain the desired densities. 
Plasma was first diluted with 10 mM Tris buffer to 
final pH 7.5. Lipoprotein fractions were dialyzed 
for 24 h at 4°C against saline containing 200 mg% 
EDTA prior to the experiments. 
2.3. Binding of different bile acids to lipoproteins 
Before evaluating binding, lipoprotein fractions 
or plasma were diluted with Tris buffer, pH 7.5. 
BS solutions in Tris buffer (pH 7.5), 0.15 M NaCl 
were added to obtain a final concentration of 
0.1 mM. After sonication they were incubated for 
24 h at 37°C prior to dialysis. 
Lipoprotein binding was determined by 
equilibrium dialysis at 37°C [9, lo]. Experiments 
were performed in a cellulose sac (Visking dialysis 
tubing 8/32, 6 mm diameter) having a minimum 
molecular mass retention of about 12 kDa. Ali- 
quots of 1 .O ml BS solution were loaded into the 
dialysis tubes, previously washed with 10 mM Tris 
buffer in saline, pH 7.5, at 37°C. 2 ml BS solution 
were dialyzed against 5 ml of the same buffer. The 
system was incubated for 36 h in a shaking bath at 
37°C. 
At the end of incubation, BA were determined in 
triplicate on the dialysate and retentate; the 
volume shift from buffer to plasma during 
equilibrium dialysis was also evaluated. Dialysis 
equilibrium for each BS was also determined to 
check that BS were completely dialyzed in the 
absence of proteins and lipoproteins. The percen- 
tage of BS bound to proteins or lipoproteins can be 
found from the BS concentration of the dialyzed 
solution (free fraction) and retentate (bound + free 
fraction). 
Values are expressed as percentage of BS bound 
to proteins or lipoprotein fractions. 
2.4. Distribution of bile salts between lipoprotein 
classes 
BS distribution between lipoprotein classes was 
studied by incubating plasma containing 4 g% 
protein and 0.1 mM BS. Sequential runs were per- 
formed at 20°C to obtain VLDL, LDL, HDL and 
the fraction of d > 1.210 g/ml. BA content of each 
fraction was determined by enzymatic methods. 
2.5. Hydrophobic properties of bile acids 
The hydrophobic character of BA was studied 
by evaluating the partition coefficient (P) between 
octan-l-01 and water [ll]. 
Octan-l-01 RP (Carlo Erba, Milan) was 
saturated with Tris buffer, pH 7.5, in saline prior 
to partitioning. BS at 0.1 mM were prepared in 
10 mM Tris buffer, pH 7.5, and saturated with 
octan-l-01. 3 ml BS solutions were added to 3 ml 
octanol and shaken. After 6 h, the tubes were cen- 
trifuged for 30 min at 6000 rpm and the aqueous 
phase analyzed for BA content. 
3. RESULTS 
3.1. Maximum binding of bile salts to lipoproteins 
Table 1 shows the composition of the plasma 
and lipoprotein fractions used for determining 
maximum BS binding. Table 2 reports the percen- 
tages of bound BS, as evaluated by experimental 
Table 1 
Composition of pooled plasma nd lipoprotein fractions 
used in dialysis experiments 
Protein= Phospho- Cho- Trigly- 
lipids lesterol cerides 
Plasma 7.0 182 229 154 
VLDL 0.035 15 39 110 
LDL 0.12 42 150 48 
HDL 0.30 107 40 16 
d > 1.210 g/ml 3.5 18 - _ 
= g/d1 
Values expressed as mg/dl 
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Table 2 
Binding of different bile acids to plasma and lipoprotein fractions 
VLDL LDL HDL d > 1.210 Plasma 
DCA 15.4 f 2.2 20.6 + 3.4 49.5 f 5.9 95.3 f 8.5 97.6 ?z 9.6 
CDCA 16.2 + 1.7 21.7 f 3.7 50.2 + 5.1 94.6 ? 9.1 96.2 + 8.3 
HDCA 9.6 + 1.4 11.7 f 1.2 28.4 + 2.8 74.3 + 7.6 81.2 + 9.3 
UDCA 10.8 f 1.0 16.1 + 1.7 27.6 + 3.1 71.7 + 6.2 76.4 f 7.7 
CA 7.3 * 0.3 9.5 f 1.2 19.7 f 1.2 48.3 f 4.5 50.2 2 4.9 
UCA 7.1 * 0.4 9.8 + 0.8 16.6 * 2.1 28.2 + 3.0 29.6 * 3.1 
Values are expressed as percentage of initial bile salt concentration (0.1 mM) 
bound to the studied fraction. Mean values + SD of 5 experiments 
Table 3 
Distribution of bile salts between the lipoprotein fractions 
VLDL LDL HDL d > 1.210 
DCA - 1.8 f 0.4 6.1 f 1.7 92.0 + 3.1 
CDCA - 2.2 + 0.3 6.7 + 1.7 91.1 + 5.2 
HDCA 0.9 f 0.3 7.6 rt 2.2 12.1 + 1.8 79.1 + 3.8 
UDCA 0.6 f 0.2 4.7 + 0.9 10.6 f 1.4 84.2 + 4.2 
CA 1.4 + 0.8 10.2 f 1.8 18.3 f 2.1 70.1 + 5.4 
UCA 2.1 + 0.6 18.2 f 2.3 29.2 rt 2.4 50.5 + 6.8 
Values (mean of 5 experiments f SD) indicate the bile acid 
content of each fraction (as percentage of the initial amount) 
dialysis. Binding to plasma and other lipoprotein 
fractions decreases along the series UCA - CA - 
UDCA - HDCA - DCA - CDCA. Binding to 
VLDL and LDL is very low for all BS studied. 
HDL are bound by some dihydroxy BA, in par- 
ticular DCA and CDCA. In contrast, maximum 
HDL binding capacity for HDCA and UDCA is 
very low. The fraction with d > 1.210 g/ml and 
total plasma show the highest binding capacity, 
markedly greater than the lipoprotein fractions. 
3.2. Distribution of bile salts among lipoprotein 
fractions 
Table 3 gives the values, expressed as percent of 
initial content, of the distribution of each BS be- 
tween the different lipoprotein fractions. BS 
distribution seems to depend on their molecular 
hydrophobicity. In fact, the most hydrophilic BA 
(UCA, CA) are less bound to the protein-rich and 
lipoprotein-free fraction (d > 1.210 g/ml). This 
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‘unbound’ BS fraction is that found in lipopro- 
teins, HDL in particular. 
CA behaves similarly to UCA, whereas DCA 
and CDCA are tightly bound to the fraction with 
d > 1.210 g/ml. UDCA and HDCA have in- 
termediate binding to HDL and LDL. 
3.3. Determination of octanol- water partition of 
bile acids 
Table 4 gives the values expressed as percent in- 
itial BA concentration remaining in the aqueous 
phase after shaking with octan-l-01. Molecular 
lipophilicity reduces the amounts of BA remaining 
in the aqueous phase. Hydrophobicity decreases 
along the series DCA - CDCA - HDCA - 
UDCA - CA - UCA. The behavior of 3a,7,& and 
3a,&-dihydroxy-S,&cholanoic acids is different 
from that expected from reversed phase HPLC 
data [lo]. 
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I UCA l 
Partition of the studied bile acids in an octanol-water 
system 
Percent in water p” 
DCA 3.2 * 1.4 30.2 
CDCA 4.1 f 1.3 23.3 
HDCA 6.2 f 1.5 23.3 
UDCA 16.7 f 2.7 4.9 
CA 71.2 f 8.4 3.7 
UCA 93.2 + 10.1 0.1 
a P (partition coefficient) evaluated from the 
retationship: 
where: Vaq = volume of aqueous phase, V,, = volume 
of organic phase, Ci = bile acid concentration in 
aqueous phase, Cr = bile acid concentration in aqueous 
phase after extraction with octanol 
4. DISCUSSION 
Our findings show that BS bind to different 
plasma components. The most hydrophobic BA 
(according to the HPLC definition of Armstrong 
and Carey [l]) are most tightly bound to proteins 
contained in the fraction with d > 1.210 g/ml. 
However, some poorly hydrophobic BA are 
strongly bound to proteins: such is the case for 
UDCA and HCA, which show greater binding to 
proteins and lipoproteins than CA, in spite of their 
shorter retention times on reverse-phase liquid 
chromatography [ 11. Therefore these results and 
other data gleaned from the literature [4, I.21 do not 
fit HPLC retention time values. 
The partition coefficient in the octan-1-ol-water 
system is widely utilized for describing the 
hydrophobic properties of drugs, and the correla- 
tion between biological activity of molecules and 
octanol-water partition is frequently addressed [2]. 
The presence of the 7@- or Ewu-hydroxy groups on 
the non-polar side of the molecule reduces both 
hydrophobicity and protein binding, and increases 
either the affinity for lipoproteins and the solubili- 
ty in the aqueous phase of the water-octanol 
system, or both. An inverse correlation was found 
between the percentage of BA binding to protein 
and the water-octanol partition (fig. 1). 
8 
ol l CA 
Fig.1. Correlation between percent of BA binding to 
plasma and percent in water in an octanol-water system 
of different bile salts. 
The molar relationship of binding between 
plasma component and BA is low (about 12) for 
apoproteins/BA, intermediate (about 57) for 
albumin/BA, and high (about 320) for phospholi- 
pid/BA. Therefore circulating phospholipids are 
the most represented components which can pick 
up BA. Although BA binding to albumin varies in 
nature and strength, when BA are not extensively 
bound to proteins, lipoproteins become more im- 
portant and transport increasing quantities of BA 
(UCA > CA > HDCA > UDCA > CDCA > 
DCA) . 
In particular, the fractions richer in phospholi- 
pids and proteins are the most active. Using photo- 
affinity labeling techniques, Kramer et al. 1131 
demonstrated that about 30% of taurocholate is 
present in HDL and 15% in LDL fraction. 
Other circulating membranes, such as erythro- 
cytes, can transport BA, but very detergent BA are 
tightly bound to proteins and so their possible 
damaging effects on the membranes are prevented. 
In conclusion, lipoproteins seem to represent a 
reserve transport system for BA in serum, especial- 
ly for hydrophilic BA less bound to proteins. The 
hydrophobic-hydrophilic balance of BA molecules 
does not correlate with their maximum binding to 
proteins and lipoproteins, or with the distribution 
into different lipoprotein classes. On the contrary, 
the binding pattern shows a good correlation with 
octanol-water partition. This test is easy to per- 
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the binding pattern shows a good correlation with 
octanol-water partition. This test is easy to per- 
form and can be used to estimate some chemico- 
physical properties of bile acids. 
PI 
[71 
REFERENCES 
PI 
PI 
[31 
141 
PI 
Armstrong, M.J. and Carey, M.C. (1982) J. Lipid 
Res. 23, 70-80. 
Hofmann, A.F. and Roda, A. (1984) J. Lipid Res. 
25, 1477-1489. 
Rudman, D. and Kendall, F.E. (1957) J. Clin. 
Invest. 36, 538-542. 
Roda, A., Cappelleri, Cl., Aldini, R., Roda, E. and 
Barbara, L. (1982) J. Lipid Res. 23, 490-495. 
Carey, M.C. (1983) in: The Enterohepatic 
Circulation (Arias, I. et al. eds) pp.429-465, 
Raven, NY. 
I91 
VOI 
ill1 
1121 
u31 
Frohlich, J., Pudek, M.R., Cormode, E.J., Sellers, 
E.M. and Abel, J.G. (1981) Clin. Chem. 27, 
1213-1216. 
Cormode, E. J., Lyster, D.M. and Israels, S. (1975) 
J. Pediatr. 86, 862-864. 
Inoue, M., Okajima, K., Nagase, S. and Morino, 
Y. (1983) Proc. Natl. Acad. Sci. USA 80, 
7654-7658. 
Duane, W.C. (1975) Biochim. Biophys. Acta 398, 
275-286. 
Duane, W.C. (1977) Biochem. Biophys. Res. Com- 
mun. 74, 223-229. 
Van Damme, M., Hanocq, M. and Molle, L. (1984) 
Pharm. Acta Helv. 59, 235-240. 
Roda, A., Hofmann, A.F. and Mysels, K. J. (1983) 
J. Biol. Chem. 258, 6362-6370. 
Kramer, W., Buscher, H.P., Gerok, W. and Kurz, 
G. (1979) Eur. J. Biochem. 102, l-9. 
276 
